Peptide record

TPDB42730

Anticancer standard
195 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB42730
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 195-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
QHWSYGLRPGGRGPKDAVRAVKGSALLPCIIVHDPNLNNSDKMKFNTYYLLEYKEYWHQLWSQIIPAHQTVKIQERTGISEVVQNSMIEDLNMYIGADFGMYFYLRSSGFKEQITRGLNRPLSQTTTQLGERVEEMEYYNSNDLDVRYVKYALAREFTLKRVNGEIVKNWVAVDYRMAGIQSYPNAPITNPLTLT
Physicochemical Analysis
C1015H1566N276O295S7
L
22579.69
8.88
26
20
81
+2
34.09
-0.488
82.46
Mammalian: 0.8 hour Yeast: 10 min E.coli: >10 hour
42860
189.82
60
Residue Composition
number
10
A
12
R
13
N
8
D
1
C
12
E
10
Q
13
G
4
H
12
I
17
L
10
K
6
M
5
F
9
P
11
S
11
T
4
W
14
Y
13
V
Amino Acid Distribution
A: 10 R: 12 N: 13 D: 8 C: 1 E: 12 Q: 10 G: 13 H: 4 I: 12 L: 17 K: 10 M: 6 F: 5 P: 9 S: 11 T: 11 W: 4 Y: 14 V: 13
Chemical Descriptors
195
C1015H1566N276O295S7
22579.69
8.88
+2
34.09
-0.488
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

CancerPPD 2.0

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.